Home›People›Michael Shine
MS

Michael Shine

CEO and director at NK-One Therapeutics.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 27, 2026·Suggest an edit

About Michael Shine

Michael Shine is CEO and director at NK-One Therapeutics.

Experience

This experience comes from Michael Shine's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Shine in the role, so the role may have started earlier or lasted longer.

NK-One Therapeutics, Inc. Current
Chief Executive Officer (2026 – Present)
Director
2026 – Present · Wayne, PA
Develops targeted treatments for people with chronic pain.
OrthoCellix Current
Member Board of Directors
2025 – Present
Ambros Therapeutics Current
Board Observer
2025 – Present
Ocugen
Senior Vice President, Commercial & Business Development
2021 – 2025
NovaPharm Therapeutics
Chief Executive Officer
2012 – 2021
Thomson Reuters
Chief Marketing Officer
2010 – 2012
Wyeth Pharmaceuticals / Pfizer
Vice President & Global Business Manager
1998 – 2010
Colgate Palmolive
Global Brand Manager
1985 – 1998

Key Colleagues at Startups

The people Michael Shine works with at each company, as listed on that company's latest Form D.

NK-One Therapeutics, Inc. · Form D, Apr 27, 2026
MP
Marco Pappagallo
CMO and director

Sources

  1. SECNK-One Therapeutics, Inc. Form D, filed Apr 27, 2026